Viewing StudyNCT00410462



Ignite Creation Date: 2024-05-05 @ 5:13 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00410462
Status: UNKNOWN
Last Update Posted: 2014-08-08
First Post: 2006-12-11

Brief Title: Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed Refractory or Metastatic Soft Tissue Sarcoma
Sponsor:
Organization: European Organisation for Research and Treatment of Cancer - EORTC